WHO

In response to World Health Organization (WHO) member states not reaching an agreement on a pandemic accord in time for the World Health Assembly this week, Oxfam International’s Health Policy Lead, Anna Marriott, said: “Negotiators have been working on drawing up a global treaty meant to prevent a repeat of the extreme vaccine apartheid between Global North and South during the COVID-19 pandemic. But time and time again in these negotiations, rich countries have danced to the tune of big pharmaceutical corporations instead of healing the deep geopolitical chasms caused by their short-sighed vaccine nationalism."

“People have become complacent about COVID-19. Our global (health) funds are fast running out of money. Vaccine inequity is getting worse,” said former UK prime minister Gordon Brown today. 

New figures from the Peoples Vaccine Alliance reveal that the companies behind two of the most successful COVID vaccines – Pfizer, BioNTech and Moderna – are making combined profits of $65,000 every minute. The figures based on the latest company reports are released as CEOs from pharmaceutical industry meet for the annual STAT summit —the equivalent of a ‘Big Pharma Davos’— from 16-18 November.

In response to the announcement that AstraZeneca is to move away from the non-profit model for COVID vaccines, Anna Marriott, Oxfam’s Health Policy Manager and spokesperson for the People’s Vaccine Alliance, said: “AstraZeneca is breaking its repeated and celebrated public promises of a non-profit vaccine for all countries for the duration of this pandemic and to never to make a profit in any low- and middle-income country from this publicly funded vaccine."
 

In response to the announcement that the World Health Organisation (WHO) has granted emergency use license for the COVID-19 vaccine, Covaxin, developed by Bharat Biotech in India, People’s Vaccine Alliance spokesperson and Oxfam Health Policy Manager, Anna Marriott, said: "Another approved vaccine to fight COVID-19 is fantastic news. We strongly encourage Bharat Biotech to show pandemic leadership and do the right thing for humanity by agreeing to share the vaccine technology and rights with the WHO's COVID Technology Access Pool, so that more manufacturers around the world can produce them.

Responding to an International Labour Organisation’s report, ILO Monitor: COVID-19 and the world of work, campaigners have called global vaccine inequality “a collective act of social and economic self-harm”.

On the eve of President Biden’s global COVID-19 summit on the side-lines of the UN General Assembly, campaigners from the People’s Vaccine Alliance are calling for world leaders to go beyond empty promises of charity and deliver bold action to increase manufacturing and access to COVID-19 vaccines around the world.

Responding to the G20 Heads of State Summit, Rebecca Gowland, Head of Inequality, Campaigns and Policy, said: “In 2020 the richest economies bolstered their resilience to Covid-19 with a $10 trillion injection while providing 2,000 times less than that – $5 billion – in debt relief to the poorest countries. In the direst global health and socio-economic crises for 100 years the G20 has failed to adequately support the poorest people in the world.

“Moderna’s discovery could be a real game-changer in the fight against COVID-19. However, on its own, Moderna can only produce enough vaccine for less than seven percent of the global population by the end of 2021, almost all of whom will be in rich countries," said Anna Marriott, Oxfam’s Health Policy Manager, in response to the announcement today from the National Institutes of Health that early data shows Moderna’s COVID-19 vaccine is nearly 95 percent effective.

“The pharmaceutical industry’s attempt to rubbish the World Health Organisation’s initiative suggests that they care more for profits than people’s health," said Anna Marriott, Health Policy Manager for Oxfam, in response to the World Health Organisation’s call for governments to back a voluntary scheme to share trial data and patents relating to vaccines and treatments for the coronavirus.